Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Robert Bitterman
CEO | Chief Executive Officer | 73 | 19/06/12 |
Caitlin Kontulis
DFI | Director of Finance/CFO | - | - |
James Cardia
CTO | Chief Tech/Sci/R&D Officer | - | 15/09/17 |
Linda M. Mahoney
PRN | Corporate Officer/Principal | - | 10/11/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Robert Bitterman
CEO | Chief Executive Officer | 73 | 19/06/12 |
Director/Board Member | 73 | 02/05/22 | |
Curtis Lockshin
BRD | Director/Board Member | 64 | 18/04/13 |
Jonathan Freeman
BRD | Director/Board Member | 56 | 07/06/17 |
Robert Ferrara
BRD | Director/Board Member | 73 | 01/10/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 4 591 700 | 4 564 638 ( 99,41 %) | 0 | 99,41 % |
Coordinate società
Phio Pharmaceuticals Corp.
11 Apex Drive Suite 300A PMB 2006
01752, Marlborough
+508-767-3861
http://www.phiopharma.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+29,77% | 49,18 Mrd | |
+1,00% | 42,11 Mrd | |
+50,47% | 40,37 Mrd | |
-5,26% | 28,85 Mrd | |
+13,68% | 26,09 Mrd | |
-22,99% | 18,71 Mrd | |
+8,22% | 13,26 Mrd | |
+32,41% | 12,32 Mrd | |
-1,62% | 11,99 Mrd |